华兰疫苗
(301207)
| 流通市值：113.28亿 | | | 总市值：113.35亿 |
| 流通股本：6.01亿 | | | 总股本：6.01亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 805,986,896.84 | 59,961,774.27 | 24,282,534.72 | 1,127,812,323.85 |
| 营业收入 | 805,986,896.84 | 59,961,774.27 | 24,282,534.72 | 1,127,812,323.85 |
| 二、营业总成本 | 757,546,402.98 | 163,447,081.23 | 49,573,022.32 | 961,283,918.27 |
| 营业成本 | 185,428,235.39 | 14,837,205.7 | 3,400,793.07 | 212,558,788.13 |
| 税金及附加 | 7,074,963.95 | 2,848,922.88 | 1,458,933.06 | 10,606,122.82 |
| 销售费用 | 401,311,273.85 | 28,993,900.37 | 14,617,192.32 | 501,385,044.85 |
| 管理费用 | 52,945,493.02 | 34,538,407.88 | 7,947,905.52 | 81,157,726.37 |
| 研发费用 | 111,781,220.66 | 82,323,158.68 | 22,115,565.91 | 162,640,277.74 |
| 财务费用 | -994,783.89 | -94,514.28 | 32,632.44 | -7,064,041.64 |
| 其中:利息费用 | 2,550,000.02 | 2,550,000.02 | 1,316,666.68 | 6,100,000.02 |
| 其中:利息收入 | 3,646,881.27 | 2,729,855.27 | 1,313,039.44 | 13,215,392.6 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 15,112,478.66 | 10,279,395.19 | 5,452,133.52 | 24,300,582.77 |
| 加:投资收益 | 55,500,965.39 | 39,067,003.76 | 20,064,785.01 | 76,072,994.64 |
| 资产处置收益 | -24,955.08 | - | - | -140,144.03 |
| 资产减值损失(新) | 12,277,453.7 | 12,277,453.7 | 1,046,468.97 | -74,225,065.72 |
| 信用减值损失(新) | 1,921,489.59 | 49,290,397.91 | 32,636,845.67 | 9,429,587.47 |
| 其他收益 | 6,123,690.36 | 4,701,403.79 | 2,558,547.64 | 12,889,666.46 |
| 四、营业利润 | 139,351,616.48 | 12,130,347.39 | 36,468,293.21 | 214,856,027.17 |
| 加:营业外收入 | 210,000 | 208,000 | - | 1,603,558.25 |
| 减:营业外支出 | 1,933,605.57 | 1,136,403.45 | 1,130,559.99 | 1,913,859.17 |
| 五、利润总额 | 137,628,010.91 | 11,201,943.94 | 35,337,733.22 | 214,545,726.25 |
| 减:所得税费用 | 5,319,410.86 | -9,595,212.86 | 2,560,661.08 | 9,030,410.5 |
| 六、净利润 | 132,308,600.05 | 20,797,156.8 | 32,777,072.14 | 205,515,315.75 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 132,308,600.05 | 20,797,156.8 | 32,777,072.14 | 205,515,315.75 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 132,308,600.05 | 20,797,156.8 | 32,777,072.14 | 205,515,315.75 |
| 扣除非经常损益后的净利润 | 86,255,749.63 | -12,784,853.85 | 15,415,789.2 | 120,390,566.59 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.22 | 0.04 | 0.06 | 0.34 |
| (二)稀释每股收益 | 0.22 | 0.04 | 0.06 | 0.34 |
| 九、综合收益总额 | 132,308,600.05 | 20,797,156.8 | 32,777,072.14 | 205,515,315.75 |
| 归属于母公司股东的综合收益总额 | 132,308,600.05 | 20,797,156.8 | 32,777,072.14 | 205,515,315.75 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-28 | 2025-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |